
Global Preimplantation Genetic Screening (PGS) Technology Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Preimplantation Genetic Screening (PGS) Technology market size will reach US$ million by 2031.
Preimplantation genetic screening (PGS) determines the chromosomal status of an embryo by screening all 23 chromosome pairs prior to transfer in an IVF cycle.
United States market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Preimplantation Genetic Screening (PGS) Technology players cover Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Coopersurgical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Preimplantation Genetic Screening (PGS) Technology Industry Forecast” looks at past sales and reviews total world Preimplantation Genetic Screening (PGS) Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected Preimplantation Genetic Screening (PGS) Technology sales for 2025 through 2031. With Preimplantation Genetic Screening (PGS) Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preimplantation Genetic Screening (PGS) Technology industry.
This Insight Report provides a comprehensive analysis of the global Preimplantation Genetic Screening (PGS) Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preimplantation Genetic Screening (PGS) Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preimplantation Genetic Screening (PGS) Technology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preimplantation Genetic Screening (PGS) Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preimplantation Genetic Screening (PGS) Technology.
This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Screening (PGS) Technology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism
Segmentation by Application:
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer
Coopersurgical
Natera
Takara Bio
Oxford Gene Technology
INVICTA
Genea
Progenesis
Igenomix
Reproductive Health and Wellness Center
Please note: The report will take approximately 2 business days to prepare and deliver.
Preimplantation genetic screening (PGS) determines the chromosomal status of an embryo by screening all 23 chromosome pairs prior to transfer in an IVF cycle.
United States market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Preimplantation Genetic Screening (PGS) Technology is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Preimplantation Genetic Screening (PGS) Technology players cover Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, Coopersurgical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Preimplantation Genetic Screening (PGS) Technology Industry Forecast” looks at past sales and reviews total world Preimplantation Genetic Screening (PGS) Technology sales in 2024, providing a comprehensive analysis by region and market sector of projected Preimplantation Genetic Screening (PGS) Technology sales for 2025 through 2031. With Preimplantation Genetic Screening (PGS) Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preimplantation Genetic Screening (PGS) Technology industry.
This Insight Report provides a comprehensive analysis of the global Preimplantation Genetic Screening (PGS) Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preimplantation Genetic Screening (PGS) Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preimplantation Genetic Screening (PGS) Technology market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preimplantation Genetic Screening (PGS) Technology and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preimplantation Genetic Screening (PGS) Technology.
This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Screening (PGS) Technology market by product type, application, key players and key regions and countries.
Segmentation by Type:
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism
Segmentation by Application:
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer
Coopersurgical
Natera
Takara Bio
Oxford Gene Technology
INVICTA
Genea
Progenesis
Igenomix
Reproductive Health and Wellness Center
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
102 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Preimplantation Genetic Screening (PGS) Technology Market Size by Player
- 4 Preimplantation Genetic Screening (PGS) Technology by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Preimplantation Genetic Screening (PGS) Technology Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.